[Effect of T-activin and irradiation with a helium-neon laser on the status of the interleukin-2-dependent component of the proliferative response of mononuclear cells in rheumatoid arthritis].
Parnes
E Ia
EIa
Alikhanov
B A
BA
Tkomachev
Iu K
IuK
Muromtsev
A V
AV
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000473:pathology / Q000628:therapy*; D002455:Cell Division / Q000187:drug effects / Q000528:radiation effects; D003131:Combined Modality Therapy; D005260:Female; D006371:Helium; D006801:Humans; D007376:Interleukin-2 / Q000097:blood* / Q000528:radiation effects; D053685:Laser Therapy; D008214:Lymphocytes / Q000187:drug effects / Q000473:pathology* / Q000528:radiation effects; D008297:Male; D008875:Middle Aged; D009356:Neon; D010455:Peptides / Q000627:therapeutic use*; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D007376:Interleukin-2; D010455:Peptides; D013949:Thymus Extracts; D006371:Helium; D009356:Neon; C036191:T-activin
Vliianie T-aktivina i izlucheniia geliĭ-neonovogo lazera na sostoianie interleĭkin-2-zavisimogo zvena proliferativnogo otveta mononuklearov pri revmatoidnom artrite.